Benefits of early treatment with natalizumab
Multiple sclerosis (MS) is characterised by neuroinflammation, demyelination and neurodegeneration occurring from the earliest phases of the disease; the impact of these pathophysiological processes...
Subcutaneous route of natalizumab administration for relapsing multiple sclerosis patients
Multiple sclerosis (MS) is an autoimmune, demyelinating and neurodegenerative disease of the central nervous system (CNS) leading to increasing disability over time and reduced health-related quality...
Atopisches Hand-Fuß-Ekzem
Ein Hand- und Fußekzem kann erhebliche Auswirkungen auf den Alltag der Betroffenen haben . Patient*innen, deren Handekzem eine atopische Ätiologie aufweist, erreichten unter einer Therapie mit dem...
EADV 2023
32. Kongress der European Academy of Dermatology and Venereology Berlin, 11. – 14. Oktober 2023 Unabhängige Berichterstattung von großen, internationalen, medizinischen Kongressen Autorin: Dr....
San Antonio Breast Cancer Symposium 2023
Daily Highlights
...
Adjuvant nivolumab versus placebo in high-risk muscle invasive urothelial carcinoma
Approximately one in five urothelial carcinomas are muscle-invasive at initial diagnosis.1 Standard management for muscle-invasive urothelial carcinoma (MIUC) is bladder sparing therapy or radical...
Anthropophile Dermatophyten – Trichophyton rubrum als Wellnessmitbringsel
Dr. med. Florian Kapp, Facharzt für Dermatologie und Venerologie (München)...
Highlights of ANZBMS Annual Scientific Meeting 2023
The Australian and New Zealand Bone and Mineral Society
With Professor Peter Ebeling Head of the Department of Medicine, School of Clinical Sciences, Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University Fellow of the...
Abemaciclib therapy in HR+/HER2– advanced breast cancer: Are CDK4/6 inhibitors created equal?
The era of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) has rapidly transformed the treatment landscape for patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor...
Glycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist
Results from the SURPASS-2 trial
Incretins are a group of metabolic hormones secreted by the gut during a meal, which convey insulinotropic signals to the pancreatic islet cells, thereby potentiating glucose-induced insulin...